Michael Dougherty

Michael R.
Dougherty currently works at AltheRx, Inc., as Director from 2013 and Viralclear Pharmaceuticals, Inc., as Director from 2020.
Mr. Dougherty also formerly worked at Genaera Corp., as President & Chief Executive Officer from 1998 to 2000, Adolor Corp., as President, Chief Executive Officer & Director from 2006 to 2011, Kalidex Pharmaceuticals, Inc., as Chief Executive Officer & Director in 2012, Celator Pharmaceuticals, Inc., as Executive Chairman from 2015 to 2016, Idera Pharmaceuticals, Inc., as Independent Director, Shire ViroPharma, Inc., as Independent Director from 2004 to 2014, Marinus Pharmaceuticals, Inc., as Independent Director from 2017 to 2022, Cempra Pharmaceuticals, Inc., as Director, Cempra, Inc., as Independent Director from 2013 to 2017, Trevena, Inc., as Independent Director from 2013 to 2023, Foundation Medicine, Inc., as Independent Director from 2016 to 2018, Aviragen Therapeutics, Inc., as Independent Non-Executive Director from 2013 to 2018, Aceragen, Inc., as Independent Director from 2022 to 2023, Centocor, Inc., as Chief Financial Officer & Senior Vice President, and Genomics Collaborative, Inc., as President & Chief Operating Officer from 2000 to 2002.
Mr. Dougherty received his undergraduate degree in 1980 from Villanova University.